Long-term Follow-up to Evaluate the Safety of LX1001 in Participants with APOE4 Homozygote Alzheimer's Disease.

Clinical Trial Grant

Duke Scholars

Principal Investigator Kim G Johnson Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychol ...

Administered By

School of Medicine

Awarded By

LEXEO Therapeutics, Inc

Start Date

April 30, 2024

End Date

January 1, 2029

Administered By

School of Medicine

Awarded By

LEXEO Therapeutics, Inc

Start Date

April 30, 2024

End Date

January 1, 2029